{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:33Z","timestamp":1792726713007,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471450"],"award-info":[{"award-number":["82471450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tjpad.2026.100515","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:16:03Z","timestamp":1772230563000},"page":"100515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework"],"prefix":"10.1016","volume":"13","author":[{"given":"Heya","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7380-7451","authenticated-orcid":false,"given":"Cuibai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2026.100515_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100515_bib0002","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tjpad.2026.100515_bib0003","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.tjpad.2026.100515_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","article-title":"The worldwide costs of dementia 2015 and comparisons with 2010","volume":"13","author":"Wimo","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100515_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113168","article-title":"Overview of therapeutic targets in management of dementia","volume":"152","author":"Malik","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tjpad.2026.100515_bib0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0007","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.amjmed.2018.01.022","article-title":"Dementia","volume":"131","author":"Gale","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.tjpad.2026.100515_bib0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.mcna.2024.09.001","volume":"109","author":"Guasp","year":"2025","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.tjpad.2026.100515_bib0009","first-page":"13","article-title":"Autoimmune encephalitis with antibodies: Anti-NMDAR, anti-AMPAR, anti-GQ1b, Anti-DPPX, anti-CASPR2, anti-LGI1, anti-RI, Anti-yo, anti-hu, anti-CV2 and anti-GABAAR, in the course of psychoses, neoplastic diseases, and paraneoplastic syndromes","author":"Braczkowski","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.tjpad.2026.100515_bib0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200406","article-title":"Assessing commercial tissue-based assays for autoimmune neurologic disorders (II): antibodies to surface antigens","volume":"12","author":"Papi","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0011","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tjpad.2026.100515_bib0012","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3348\/kjr.2023.1307","article-title":"Autoimmune encephalitis: insights into immune-mediated Central nervous system injury","volume":"25","author":"Pai","year":"2024","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10408363.2023.2247482","article-title":"General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis","volume":"61","author":"Masciocchi","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0014","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbi.2021.05.017","article-title":"Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder","volume":"96","author":"Giannoccaro","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.tjpad.2026.100515_bib0016","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200137","article-title":"Antibodies associated with autoimmune encephalitis in patients with presumed neurodegenerative dementia","volume":"10","author":"Bastiaansen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00406-014-0493-9","article-title":"Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients","volume":"264","author":"Busse","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0018","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types","volume":"1","author":"Doss","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0019","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s40120-025-00828-5","article-title":"Cognitive function and proteomic changes in patients with autoantibody-positive neurodegenerative dementia","volume":"14","author":"Gong","year":"2025","journal-title":"Neurol Ther"},{"key":"10.1016\/j.tjpad.2026.100515_bib0020","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001039","article-title":"Autoimmune encephalitis resembling dementia syndromes","volume":"8","author":"Bastiaansen","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0021","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00415-020-09825-0","article-title":"Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis","volume":"268","author":"Gibson","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2019.02.003","article-title":"A case of treatable dementia with lewy bodies remarkably improved by immunotherapy","volume":"330","author":"Abe","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0023","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/ene.12939","article-title":"Slowly progressive LGI1 encephalitis with isolated late-onset cognitive dysfunction: a treatable mimic of Alzheimer's disease","volume":"23","author":"Marquetand","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0024","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","article-title":"IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment","volume":"78","author":"Pr\u00fcss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100515_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.673347","article-title":"Case report: coexistence of anti-AMPA receptor encephalitis and positive biomarkers of Alzheimer's disease","volume":"12","author":"Song","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0026","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tjpad.2026.100515_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1412813","article-title":"Brain-targeting autoantibodies in patients with dementia","volume":"15","author":"Staabs","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115460","article-title":"Update on autoimmune dementia and its precursors","volume":"482","author":"Hansen","year":"2025","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.tjpad.2026.100515_bib0029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neures.2014.06.002","article-title":"N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias","volume":"85","author":"Busse","year":"2014","journal-title":"Neurosci Res"},{"key":"10.1016\/j.tjpad.2026.100515_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00406-017-0768-z","article-title":"Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias","volume":"268","author":"Busse","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/935379","article-title":"Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia","volume":"2014","author":"\u00c7oban","year":"2014","journal-title":"Behav Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0032","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100515_bib0033","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040837","article-title":"Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived Human neurons","volume":"10","author":"Ryding","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tjpad.2026.100515_bib0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-023-02625-6","article-title":"Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease","author":"Berger-Sieczkowski","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0037","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2019.10.015","article-title":"Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure","volume":"86","author":"Palese","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2026.100515_bib0038","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbi.2024.03.018","article-title":"Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features","volume":"118","author":"Italia","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.tjpad.2026.100515_bib0039","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1038\/s41598-017-06117-y","article-title":"Anti-AMPA GluA3 antibodies in frontotemporal dementia: a new molecular target","volume":"7","author":"Borroni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjpad.2026.100515_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13405","article-title":"Antibodies in neurological diseases: established, emerging, explorative","author":"Li","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tjpad.2026.100515_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030666","article-title":"Neural surface antibodies and neurodegeneration: clinical commonalities and pathophysiological relationships","volume":"11","author":"Giannoccaro","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.tjpad.2026.100515_bib0042","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbi.2022.10.016","article-title":"Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: analysis of 49 autoantibodies in over 7000 subjects","volume":"108","author":"Daguano Gastaldi","year":"2023","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.tjpad.2026.100515_bib0043","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0044","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.tjpad.2026.100515_bib0045","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","article-title":"Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy","volume":"18","author":"Dalakas","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tjpad.2026.100515_bib0046","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0047","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0048","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-025-02459-z","article-title":"Immunotherapy for autoimmune encephalitis","volume":"11","author":"Cheng","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.tjpad.2026.100515_bib0049","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2026.100515_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.856876","article-title":"Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: retrospective case series","volume":"14","author":"Hansen","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0051","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2026.100515_bib0052","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamaneurol.2024.0590","article-title":"Semantic variant of primary progressive aphasia with glycine receptor \u03b11 autoantibodies","volume":"81","author":"Chen","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0053","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/practneurol-2021-003073","article-title":"Paraneoplastic neurological syndromes: a practical approach to diagnosis and management","volume":"22","author":"Binks","year":"2022","journal-title":"Pract Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0054","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(18)30279-5","article-title":"Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis","volume":"17","author":"Gelfand","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0056","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaneurol.2021.0249","article-title":"Encephalitis induced by immune checkpoint inhibitors: a systematic review","volume":"78","author":"Velasco","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0057","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","article-title":"LGI1 antibody encephalitis: acute treatment comparisons and outcome","volume":"93","author":"Rodriguez","year":"2022","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.tjpad.2026.100515_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.70158","article-title":"Cytokine, chemokine, and neurofilament light chain signatures in LGI1 autoimmune encephalitis","author":"Aboseif","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0059","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1007\/s00415-022-11224-6","article-title":"The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data","volume":"269","author":"Blackman","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1111063","article-title":"Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1","volume":"14","author":"Zong","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0061","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0062","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0063","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","article-title":"Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited","volume":"71","author":"Steiner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100515_bib0064","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41398-021-01701-3","article-title":"Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis","volume":"11","author":"Theorell","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100515_bib0065","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1038\/s41598-024-55995-6","article-title":"Seroprevalence of neuronal antibodies in diseases mimicking autoimmune encephalitis","volume":"14","author":"Vaisvilas","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjpad.2026.100515_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101858","article-title":"Detection of autoantibodies in central nervous system inflammatory disorders: clinical application of cell-based assays","volume":"38","author":"Molina","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.tjpad.2026.100515_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00841","article-title":"Detection methods for autoantibodies in suspected autoimmune encephalitis","volume":"9","author":"Ricken","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103101","article-title":"Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity","volume":"62","author":"Padoan","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tjpad.2026.100515_bib0069","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0070","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0071","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","article-title":"Verkman AS. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica","volume":"126","author":"Ratelade","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0072","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0073","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0074","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4103\/1673-5374.355742","article-title":"Anti-IgLON5 disease: a novel topic beyond neuroimmunology","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.tjpad.2026.100515_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-024-02805-y","article-title":"Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy","volume":"148","author":"Gelpi","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0076","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WCO.0000000000001271","article-title":"New knowledge on anti-IgLON5 disease","volume":"37","author":"Gaig","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0077","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-022-02520-z","article-title":"Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice","volume":"19","author":"Ni","year":"2022","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0078","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","article-title":"Tau proteins and tauopathies in Alzheimer's disease","volume":"38","author":"Chong","year":"2018","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0079","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0081","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: A link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0082","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061024","article-title":"Pilot study of the effects of chronic intracerebroventricular infusion of Human anti-IgLON5 disease antibodies in mice","volume":"11","author":"Alvente","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tjpad.2026.100515_bib0083","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-170189","article-title":"Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy","volume":"59","author":"Cagnin","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.tjpad.2026.100515_bib0084","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000651","article-title":"Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy","volume":"7","author":"Erro","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jnnp-2012-304644","article-title":"TDP-43 frontotemporal lobar degeneration and autoimmune disease","volume":"84","author":"Miller","year":"2013","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.tjpad.2026.100515_bib0086","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/WCO.0000000000000665","article-title":"Immunological signatures in frontotemporal lobar degeneration","volume":"32","author":"Sirkis","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0087","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000517238","article-title":"Role of autoantibodies in neurodegenerative dementia: an emerging association","volume":"50","author":"Arshad","year":"2021","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.tjpad.2026.100515_bib0088","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","article-title":"Frontotemporal dementia and its subtypes: a genome-wide association study","volume":"13","author":"Ferrari","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0089","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1212\/NXI.0000000000000301","article-title":"Increased prevalence of autoimmune disease within C9 and FTD\/MND cohorts: completing the picture","volume":"3","author":"Miller","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010077","article-title":"NMDA and AMPA receptor autoantibodies in brain disorders: from molecular mechanisms to clinical features","volume":"10","author":"Gardoni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tjpad.2026.100515_bib0091","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.3717","article-title":"Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia","volume":"20","author":"Gascon","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2026.100515_bib0092","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fnins.2019.00304","article-title":"Toward a glutamate hypothesis of frontotemporal dementia","volume":"13","author":"Benussi","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0093","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jalm\/jfab127","article-title":"Clinical sensitivity, specificity, and predictive value of neural antibody testing for autoimmune encephalitis","volume":"7","author":"Budhram","year":"2022","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.tjpad.2026.100515_bib0094","first-page":"520","article-title":"Neural antibodies in first-episode psychosis patients with warning signs for autoimmune encephalitis. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of","volume":"22","author":"Pav\u0103l","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tjpad.2026.100515_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100515_bib0096","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200311","article-title":"IGLON5 Frequency in idiopathic REM sleep behavior disorder: A multicenter study","volume":"11","author":"Postuma","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0097","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7861\/clinmed.2020-0241","article-title":"Update on the diagnosis and management of autoimmune encephalitis","volume":"20","author":"Ellul","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.tjpad.2026.100515_bib0098","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0099","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","article-title":"Synaptic and neuronal autoantibody-associated psychiatric syndromes: controversies and hypotheses","volume":"8","author":"Al-Diwani","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100515_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/frdem.2023.1227823","article-title":"Case report: Anti-ARHGAP26 autoantibodies in atypical dementia with lewy bodies","volume":"2","author":"Hansen","year":"2023","journal-title":"Front Dement"},{"key":"10.1016\/j.tjpad.2026.100515_bib0101","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbi.2024.01.220","article-title":"KCNA2 IgG autoimmunity in neuropsychiatric diseases","volume":"117","author":"Arlt","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.tjpad.2026.100515_bib0102","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13111537","article-title":"Persisting verbal memory encoding and recall deficiency after mGluR5 autoantibody-mediated encephalitis","volume":"13","author":"Hansen","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837376","article-title":"Cerebrospinal fluid total tau protein correlates with longitudinal, progressing cognitive dysfunction in anti-neural autoantibody-associated dementia and Alzheimer's dementia: a case-control study","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0104","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12010015","article-title":"Dysfunctional learning and verbal memory in patients with elevated tau protein levels and serum recoverin autoantibodies-case series and review","volume":"12","author":"Hansen","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.tjpad.2026.100515_bib0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00702-021-02316-0","article-title":"Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort","volume":"128","author":"Hansen","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.tjpad.2026.100515_bib0106","first-page":"1","article-title":"Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults","author":"Hahn","year":"2024","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-025-13094-0","article-title":"Neurodegeneration and the immune system: lessons from autoimmune encephalitis","volume":"272","author":"Campetella","year":"2025","journal-title":"J Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719432","article-title":"CSF-neurofilament light chain levels in NMDAR and LGI1 encephalitis: a national cohort study","volume":"12","author":"Nissen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1043723","article-title":"The study of neural antibodies in neurology: a practical summary","volume":"13","author":"Fern\u00e1ndez-Fournier","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70779","article-title":"Indications and diagnostic yield of paraneoplastic and autoimmune encephalitis antibody testing: a retrospective cohort study","volume":"15","author":"Ford","year":"2025","journal-title":"Brain Behav"},{"key":"10.1016\/j.tjpad.2026.100515_bib0112","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fimmu.2018.00703","article-title":"Overinterpretation and overtreatment of low-titer antibodies against contactin-associated protein-2","volume":"9","author":"Bien","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tjpad.2026.100515_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110746","article-title":"Autoimmune central nervous system disorders: antibody testing and its clinical utility","volume":"126","author":"Gilligan","year":"2024","journal-title":"Clin Biochem"},{"key":"10.1016\/j.tjpad.2026.100515_bib0114","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200410","article-title":"Assessing commercial tissue-based assays for autoimmune neurologic disorders (I): antibodies to intracellular antigens","volume":"12","author":"Milano","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0115","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.tjpad.2026.100515_bib0116","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41380-017-0011-3","article-title":"Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model","volume":"24","author":"Pan","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.tjpad.2026.100515_bib0117","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1038\/s41380-021-01392-8","article-title":"NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance","volume":"27","author":"Arinrad","year":"2022","journal-title":"Mol Psychiatry"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:01:06Z","timestamp":1792724466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2274580726000397"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100515","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100515"}}